Professor Yip, Cheuk-Fung Terry
Associate Professor,
Department of Medicine and Therapeutics
Co-Director (Data Science),
CUHK Medical Data Analytics Centre,
Faculty of Medicine,
The Chinese University of Hong Kong
Chronic hepatitis B (CHB) remains a major global health burden, affecting approximately 258 million individuals worldwide in 2022 and causing an estimated 1.1 million deaths annually from cirrhosis and hepatocellular carcinoma (HCC).1 With
April 30, 2026
